One of Valeant Pharmaceuticals’ creditors has told the company that they will call a default on the company, Dow Jones reports.
More on this to come…
BREAKING: Big Valeant bond investor Centerbridge notifies company of intention to call a default – Dow Jones, citing sources
— CNBC Now (@CNBCnow) April 12, 2016
NOW WATCH: Money & Markets videos
Business Insider Emails & Alerts
Site highlights each day to your inbox.